Patents by Inventor Eric Aubin

Eric Aubin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Salts and solid forms of a monobactam antibiotic
    Patent number: 10919887
    Abstract: The invention provides new solid forms, salts and polymorphs of 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropanecarboxylic acid (referred to herein as Compound X), pharmaceutical compositions containing them, and processes for their manufacture and use in therapy.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: February 16, 2021
    Assignee: Novartis AG
    Inventors: Eric Aubin, Anthony Casarez, Andreas Fisch, Zaixing Li, Mika Lindvall, Heinz Ernst Moser, Michael Mutz, Folkert Reck, Bernd Ulrich Riebesehl, Marc Schoenhentz, Vijay Sethuraman, Robert Lowell Simmons
  • SALTS AND SOLID FORMS OF A MONOBACTAM ANTIBIOTIC
    Publication number: 20180273522
    Abstract: The invention provides new solid forms, salts and polymorphs of 1-(((Z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropanecarboxylic acid (referred to herein as Compound X), pharmaceutical compositions containing them, and processes for their manufacture and use in therapy.
    Type: Application
    Filed: September 20, 2016
    Publication date: September 27, 2018
    Inventors: Eric AUBIN, Anthony CASAREZ, Andreas FISCH, Zaixing LI, Mika LINDVALL, Heinz Ernst MOSER, Michael MUTZ, Folkert RECK, Bernd Ulrich RIEBESEHL, Marc SCHOENHENTZ, Vijay SETHURAMAN, Robert Lowell SIMMONS
  • TLR3 Agonist Compositions
    Publication number: 20110076296
    Abstract: The present invention relates generally to the fields of medicine. More specifically, the present invention relates to improved TLR3 agonists. The present invention provides novel dsRNA such as polyAU composition useful in the treatment of TLR3 related diseases, uses and preparations thereof.
    Type: Application
    Filed: April 22, 2009
    Publication date: March 31, 2011
    Applicant: INNATE PHARMA S.A.
    Inventors: Eric Aubin, Christian Belmant, Laurent Gauthier, Yannis Morel, Carine Paturel, Delphine Bregeon
  • Phosphoantigen Salts Of Organic Bases And Methods For Their Crystallization
    Publication number: 20080300222
    Abstract: The invention provides novel phosphoantigen salts and novel crystalline phases of phosphoantigens salts, that the latter including non-solvated polymorphs, and solvates useful as pharmaceuticals. The invention also provides pharmaceutical compositions comprising, and processes for making, novel phosphoantigen crystalline phases. Methods of using such compositions for the treatment of disease, immunostimulatory or immune response modifying use are also provided. The invention also provides method for obtaining phosphoantigen crystals as well as highly pure phosphoantigen compositions.
    Type: Application
    Filed: October 5, 2006
    Publication date: December 4, 2008
    Applicant: Innate Pharma
    Inventors: Gerard Coquerel, Eric Aubin